Inactive Instrument

Press Releases ENTST BIO Other OTC

Equities

End-of-day quote Other OTC Other stock markets
- ^USD	-

2020	Entest Group, Inc. Reports Earnings Results for the First Quarter Ended November 30, 2019	CI
2019	Entest Group, Inc. Reports Earnings Results for the Full Year Ended August 31, 2019	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

ENTEST : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	21/20/21	AQ
ENTEST GROUP, INC. : Changes in Registrant's Certifying Accountant (form 8-K)	08/20/08	AQ
ENTEST : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	20/19/20	AQ
Entest Group, Inc. : Declares Property Dividend of 3,000,000 Common Shares of Zander Therapeutics Inc.	10/18/10	PR
Entest Biomedical : Zander Therapeutics, Inc. Announces Appointment of Dr. Robin Beat Gasser to Scientific Advisory Board	13/17/13	PR
Entest BioMedical : Settles $841,531 of Principal Indebtedness Through the Issuance of Equity Securities	31/17/31	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer